The purpose of this legislation, known as the MIRACLE Act of 2025, is to address neonatal abstinence syndrome (NAS), a condition affecting newborns who are exposed to drugs while in the womb. The act aims to direct the Secretary of Health and Human Services to conduct a comprehensive study on NAS, focusing on its prevalence and the health outcomes for both infants and mothers, particularly in relation to pediatric transitional care facilities.